Quantcast

Latest Hypercholesterolemia Stories

2014-09-15 16:29:14

Patients starting on generic statins vs. branded statins had an eight percent lower rate of cardiovascular events and death WOONSOCKET, R.I., Sept. 15, 2014 /PRNewswire/ -- A new study by researchers at CVS Health (NYSE: CVS) and Brigham and Women's Hospital published today in the Annals of Internal Medicine, is the first to investigate whether starting on a generic versus a brand-name drug for the treatment of high cholesterol is associated with improved health outcomes. The...

2014-09-15 16:26:30

LONDON, Sept. 15, 2014 /PRNewswire/ -- INTRODUCTIONWorldwide statistics indicate that there is a high cholesterol burden despite the presence of many cholesterol-lowering drugs in the market. Out of all the available options, statins have been ubiquitously prescribed over the last 25 years. Researchers have concluded that reduction of plasma LDL cholesterol (LDLC) is the cornerstone of assessing heart risk. Irrespective of baseline cholesterol concentration, each mmol/L LDLC reduction...

2014-09-10 23:11:45

According to the Center for Disease Control and Prevention, approximately one in every six Americans has high cholesterol. New York Times and USA Today Best Selling author, Sanjay Jain, M.D. MBA explains how to identify signs of high cholesterol and reduce cholesterol levels without the use of expensive medications. Washington, DC (PRWEB) September 10, 2014 Recent statistics from the Center for Disease Control and Prevention show that 17% of Americans--one out of every six adults--have...

2014-09-08 23:02:12

http://www.heartbeatexperts.com/ -- This Flash Report is a top-line view into Heartbeat Experts’ perspectives on stakeholder management needs for the Hypercholesterolemia-Hyperlipidemia market. New York, US (PRWEB) September 08, 2014 This Flash Report is a top-line view into Heartbeat Experts’ perspectives on stakeholder management needs for the Hypercholesterolemia-Hyperlipidemia market. Download the flash report to speak with Heartbeat Experts on stakeholder strategies for any...

2014-09-02 08:29:42

Represents First Marketing Authorization Application in the European Union for a PCSK9 Inhibitor THOUSAND OAKS, Calif., Sept. 2, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) via the centralized procedure for evolocumab seeking approval for the treatment of high cholesterol. Evolocumab is an investigational fully human monoclonal antibody that inhibits proprotein convertase...

2014-08-28 08:28:39

Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Aug. 28, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 YUKAWA-2 (StudY of LDL-Cholesterol Reduction Using a Monoclonal PCSK9 Antibody in Japanese Patients With Advanced Cardiovascular Risk) study evaluating evolocumab in combination with statin therapy in Japanese patients with high cardiovascular risk and high cholesterol met its co-primary endpoints: the percent...

2014-08-28 08:28:27

Represents First BLA Submission for a PCSK9 Inhibitor THOUSAND OAKS, Calif., Aug. 28, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for evolocumab seeking approval for the treatment of high cholesterol. Evolocumab is an investigational fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that reduces the liver's ability to...

2014-08-20 23:03:06

The research organization offers tips on how to help lower cholesterol. San Antonio, TX (PRWEB) August 20, 2014 Texas Medical Research Associates is looking for candidates to participate in their new study. The study will help test the effectiveness of a new drug looking to help lower cholesterol. People who suffer from high cholesterol may be eligible to participate in the study. According to the American Heart Association, too much cholesterol in the blood can lead to cardiovascular...

statins
2014-08-17 02:00:52

Traci Klein, Mayo Clinic A Mayo Clinic task force challenges some recommendations in the updated guideline for cholesterol treatment unveiled by the American College of Cardiology (ACC) and American Heart Association (AHA) in 2013. The task force concludes, based on current evidence, that not all patients encouraged to take cholesterol-lowering medications, such as statins, may benefit from them and that the guideline missed some important conditions that might benefit from medication....

2014-08-12 12:29:20

LONDON, Aug. 12, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Hypercholesterolemia Market 2014-2018https://www.reportbuyer.com/product/2183843/Global-Hypercholesterolemia-Market-2014-2018.html About HypercholesterolemiaHypercholesterolemia is defined as a condition characterized by abnormally high levels of total cholesterol and LDL cholesterol in the blood. High cholesterol levels, in turn, can lead to cardiovascular diseases such as...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.